Upgrade to SI Premium - Free Trial

Amneal Pharmaceuticals (AMRX)

17.92 -0.05 (0.28%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/26)

Latest Headlines

FDA approves new Amneal iohexol injection strengths for imaging use July 17, 2026 8:00 AM - StreetInsider Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations July 17, 2026 8:00 AM - StreetInsider Amneal Pharmaceuticals (AMRX) PT Raised to $23 at UBS July 15, 2026 8:53 AM - StreetInsider Amneal to Report Second Quarter 2026 Results on July 30, 2026 July 9, 2026 4:05 PM - StreetInsider Alkermes terminates authorized generic supply deal with Amneal July 8, 2026 8:10 AM - StreetInsider FDA selects seven participants for precheck pilot program to advance U.S. drug manufacturing June 29, 2026 4:28 PM - StreetInsider FDA selects 7 companies for domestic drug manufacturing pilot June 29, 2026 4:20 PM - StreetInsider Form DEFM14A Amneal Pharmaceuticals, June 29, 2026 6:04 AM - SEC Filing EU panel backs Hopledo for Parkinson's motor fluctuations June 29, 2026 3:00 AM - StreetInsider Zambon and Amneal Announce Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations June 29, 2026 3:00 AM - StreetInsider Form PREM14A Amneal Pharmaceuticals, For: Jun 18 June 18, 2026 5:01 PM - SEC Filing Dispensary of Hope Launches "Hope Alliance" Campaign with Support from Amneal Pharmaceuticals June 10, 2026 10:09 AM - PR NewsWire Amneal reports positive interim results for Parkinson's drug CREXONT June 5, 2026 8:00 AM - StreetInsider Amneal reports positive interim results for CREXONT in Parkinson's study June 5, 2026 8:00 AM - StreetInsider Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's Disease June 5, 2026 8:00 AM - Globe NewsWire Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's Disease June 5, 2026 8:00 AM - StreetInsider Amneal receives FDA approval for romidepsin injection solution June 4, 2026 8:00 AM - StreetInsider Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution June 4, 2026 8:00 AM - StreetInsider Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 1, 2026 8:00 AM - StreetInsider Amneal Pharmaceuticals (AMRX) PT Raised to $16 at Barclays May 20, 2026 4:19 AM - StreetInsider Form 4 Amneal Pharmaceuticals, For: May 11 Filed by: Autor Deborah M. May 12, 2026 4:11 PM - SEC Filing Form 144 Amneal Pharmaceuticals, Filed by: Autor Deborah M. May 11, 2026 6:57 PM - SEC Filing Form 4 Amneal Pharmaceuticals, For: May 06 Filed by: BUCHI J KEVIN May 8, 2026 4:29 PM - SEC Filing Form 4 Amneal Pharmaceuticals, For: May 06 Filed by: Autor Deborah M. May 8, 2026 4:28 PM - SEC Filing Form 4 Amneal Pharmaceuticals, For: May 06 Filed by: George Jeffrey P. May 8, 2026 4:28 PM - SEC Filing Form 4 Amneal Pharmaceuticals, For: May 06 Filed by: Patel Gautam May 8, 2026 4:27 PM - SEC Filing Form 4 Amneal Pharmaceuticals, For: May 06 Filed by: Kiely John May 8, 2026 4:24 PM - SEC Filing Form 4 Amneal Pharmaceuticals, For: May 06 Filed by: Nark Ted C May 8, 2026 4:24 PM - SEC Filing Form 4 Amneal Pharmaceuticals, For: May 06 Filed by: MEISTER PAUL M May 8, 2026 4:23 PM - SEC Filing Form 4 Amneal Pharmaceuticals, For: May 06 Filed by: Yanai Shlomo May 8, 2026 4:22 PM - SEC Filing Form 10-Q Amneal Pharmaceuticals, For: Mar 31 May 7, 2026 4:27 PM - SEC Filing Form 8-K Amneal Pharmaceuticals, For: May 06 May 7, 2026 4:18 PM - SEC Filing Form 8-K Amneal Pharmaceuticals, For: May 07 May 7, 2026 4:10 PM - SEC Filing Amneal Reports First Quarter 2026 Financial Results May 7, 2026 4:01 PM - StreetInsider Form SCHEDULE 13G Amneal Pharmaceuticals, Filed by: BlackRock, Inc. April 27, 2026 4:15 PM - SEC Filing Full Article List